This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Baird analyst Catherine Schulte downgraded the rating for Qiagen N.V. (NYSE:QGEN) from Outperform to Neutral and lowered the price target from $52 to $42. Qiagen shares closed at $40.01 on Tuesday. See how other analysts view this stock.
• Baird analyst Catherine Schulte downgraded Bio-Techne Corporation (NASDAQ:TECH) from Outperform to Neutral and lowered the price target from $88 to $68. Bio-Techne shares closed at $65.29 on Tuesday. See how other analysts view this stock.
• Morgan Stanley analyst Keith Weiss downgraded Workday, Inc. (NASDAQ:WDAY) from Overweight to Equal-Weight and lowered the price target from $330 to $275. Workday shares closed at $265.72 on Tuesday. See how other analysts view this stock.
• B. Riley Securities analyst Kyle Bauser downgraded the rating for Tactile Systems Technology, Inc. (NASDAQ:TCMD) from Buy to Neutral and slashed the price target from $23 to $18. Tactile Systems shares closed at $17.86 on Tuesday. See how other analysts view this stock.
• Cantor Fitzgerald analyst Kristen Kluska downgraded Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) from Overweight to Neutral and lowered the price target from $57 to $36. Supernus Pharmaceuticals shares closed at $39.75 on Tuesday. See how other analysts view this stock.

Considering buying WDAY stock? Here’s what analysts think:

Read This Next:

• Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter